4 Top Pharmaceutical Stocks to Buy for Market Safety
A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to outperform this year.
A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to outperform this year.
With solar companies supplying strong earnings reports and excitement over the newly created yieldco in the industry, it is easy to see why the RBC team is bullish.
In the wake of the Federal Reserve Dodd-Frank Act stress tests, Jefferies thinks these four banks will see the biggest increases in dividend yields.
A new report from Merrill Lynch takes a very long look at the S&P 500 and current market conditions. It makes a very solid case that investors should remain in the stock market.
A new research report from the Information Technology and Hardware analysts at UBS tracks the stocks that are the most overbought and oversold on a relative strength basis.
While not the least bit surprising, given the big advance over the past year, some insider sales this past week were pretty staggering in size.
One thing we have noticed as the market has crept steadily higher this year is that insider buying has never hit a wall.
A new research report from Credit Suisse spotlights good stocks on which very few analysts on Wall Street provide research.
From a massive list of stocks that are in the climate change and extreme weather theme at Merrill Lynch, we zeroed in on the firm's top alternative energy companies.
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
The oil services trade is still a contrarian one, to say the least. The pain in the industry is not going away anytime soon, so sticking with the top names that weathered downturns before…
Here are five new members of the Credit Suisse Top Picks list in five separate market sectors. They look poised for a solid remainder of 2015.
24/7 Wall St. screened the Merrill Lynch SMID-Cap Alpha list for five stocks to buy now with exceptional upside potential.
A new report from UBS shows some serious changes made to the firm's Equity Focus list for March.
Four semiconductor stocks rated Overweight at J.P. Morgan should see a direct benefit from the new Galaxy S6.
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
Merrill Lynch speculation of a recombination of CBS and Viacom prompted us to scan the firm's list of media stocks rated Buy that could also hold big value for investors now.
Here are four high-yielding health care real estate investment trust currently rated Overweight by RBC analysts.
All the major money management firms that run exchange traded funds have to do regular quarterly rebalances to reset their portfolios to the proper allocation levels.
Owning a few top European stocks in a well-balanced portfolio makes good sense at this juncture, especially with the U.S. markets hovering near all-time highs.